logo
Select company
Select metric
$ -12.85MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
23
Sector
56
Industry
43
History
18
$ 4.29Close
$ 2.32 - $ 281.25 52-Week Range
Ticker Information

Ticker

BNBX

Company Name

APPLIED DNA SCIENCES INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

APPLIED DNA SCIENCES INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BNBX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 332.59K$ -13.19M$ -12.85M
3/31/2025$ 388.4K$ -7.36M$ -6.97M
12/31/2024$ 456.05K$ -8.53M$ -8.07M
9/30/2024$ 696.42K$ -6.99M$ -6.3M
6/30/2024$ 949.12K$ -7.29M$ -6.34M
3/31/2024$ 1.16M$ -12.27M$ -11.1M
12/31/2023$ 1.32M$ -7.21M$ -5.89M
9/30/2023$ 1.36M$ -9.95M$ -8.58M
6/30/2023$ 1.36M$ -7.03M$ -5.67M
3/31/2023$ 1.33M$ -5.05M$ -3.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • APPLIED DNA SCIENCES INC's latest trailing twelve months (TTM) EBITDA stands at $ -12.63M.
  • Over the past 5 years, APPLIED DNA SCIENCES INC's average EBITDA has been $ -9.66M.
  • The median EBITDA for APPLIED DNA SCIENCES INC during this period was $ -9.72M
  • APPLIED DNA SCIENCES INC reached its highest EBITDA over the past 5 years at $ -3.72M.
  • The lowest EBITDA recorded by APPLIED DNA SCIENCES INC in the same timeframe $ -14.77M

APPLIED DNA SCIENCES INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
ISPC : ISPECIMEN INC $ -8.26MCPHI : CHINA PHARMA HOLDINGS INC $ -1.74MXBIO : XENETIC BIOSCIENCES INC $ -3.08MNAOV : NANOVIBRONIX INC $ -4.33MINM : INMED PHARMACEUTICALS INC $ -7.26MWORX : SCWORX CORP $ -1.25MSPRB : SPRUCE BIOSCIENCES INC $ -45.81MONCO : ONCONETIX INC $ -43.75MNDRA : ENDRA LIFE SCIENCES INC $ -8.59MNBY : NOVABAY PHARMACEUTICALS INC $ 3.61M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for APPLIED DNA SCIENCES INC is calculated as follows: EBIT [ $ -12.91M ] + DepAmor [ $ 285.73K ]
(=) EBITDA [ $ -12.63M ]

BNBX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -14.77M

Minimum

Dec 31, 2020

$ -3.72M

Maximum

Mar 31, 2023

$ -9.66M

Average

$ -9.72M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M